Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah Persaud

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
Frontiers in Immunology|March 6, 2024
Low unspliced cell-associated HIV RNA in early treated adolescents living with HIV on long suppressive ARTKathleen Gärtner, Sara Domínguez-Rodríguez, Judith Heaney, et al.
The Lancet. HIV|July 26, 2024
Analytical treatment interruption in children living with HIV: position statement from the EPIICAL consortiumLouise Kuhn, Shaun Barnabas, Nicola Cotugno, et al.
The Journal of Infectious Diseases|March 19, 2021
Characterization of Human Immunodeficiency Virus (HIV) Infection in Cisgender Men and Transgender Women Who Have Sex With Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083Mark A Marzinke, Beatriz Grinsztejn, Jessica M Fogel, et al.
Antimicrobial Agents and Chemotherapy|March 30, 2023
Extended Analysis of HIV Infection in Cisgender Men and Transgender Women Who Have Sex with Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083Mark A Marzinke, Jessica M Fogel, Zhe Wang, et al.
The Journal of Infectious Diseases|March 18, 2022
Characterization of Human Immunodeficiency Virus (HIV) Infections in Women Who Received Injectable Cabotegravir or Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Prevention: HPTN 084Susan H Eshleman, Jessica M Fogel, Estelle Piwowar-Manning, et al.
Science Translational Medicine|May 6, 2026
VRC01 with antiretroviral initiation in infants is well tolerated, and higher concentrations associate with greater HIV-1 DNA declinesAlka Khaitan, Jane C Lindsey, Edmund V Capparelli, et al.
The Lancet. HIV|February 26, 2026
Recommendations from the 2nd Consensus Workshop on Analytical Treatment Interruption in HIV Research TrialsThumbi Ndung'u, Krista L Dong, Donn J Colby, et al.
The Lancet. HIV|March 20, 2019
Recommendations for analytical antiretroviral treatment interruptions in HIV research trials-report of a consensus meetingBoris Julg, Lynda Dee, Jintanat Ananworanich, et al.
Nature Medicine|July 12, 2016
International AIDS Society global scientific strategy: towards an HIV cure 2016Steven G Deeks, Sharon R Lewin, Anna Laura Ross, et al.
Journal of Virus Eradication|July 21, 2025
Achieving the global agenda toward HIV cure calls for establishing a research-for-cure academy in West and Central AfricaAude Christelle Ka'e, Collins Ambe Chenwi, Livo Esemu, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Frontiers in Immunology|March 6, 2024
Low unspliced cell-associated HIV RNA in early treated adolescents living with HIV on long suppressive ARTKathleen Gärtner, Sara Domínguez-Rodríguez, Judith Heaney, et al.
The Lancet. HIV|July 26, 2024
Analytical treatment interruption in children living with HIV: position statement from the EPIICAL consortiumLouise Kuhn, Shaun Barnabas, Nicola Cotugno, et al.
The Journal of Infectious Diseases|March 19, 2021
Characterization of Human Immunodeficiency Virus (HIV) Infection in Cisgender Men and Transgender Women Who Have Sex With Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083Mark A Marzinke, Beatriz Grinsztejn, Jessica M Fogel, et al.
Antimicrobial Agents and Chemotherapy|March 30, 2023
Extended Analysis of HIV Infection in Cisgender Men and Transgender Women Who Have Sex with Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083Mark A Marzinke, Jessica M Fogel, Zhe Wang, et al.
The Journal of Infectious Diseases|March 18, 2022
Characterization of Human Immunodeficiency Virus (HIV) Infections in Women Who Received Injectable Cabotegravir or Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Prevention: HPTN 084Susan H Eshleman, Jessica M Fogel, Estelle Piwowar-Manning, et al.
Science Translational Medicine|May 6, 2026
VRC01 with antiretroviral initiation in infants is well tolerated, and higher concentrations associate with greater HIV-1 DNA declinesAlka Khaitan, Jane C Lindsey, Edmund V Capparelli, et al.
The Lancet. HIV|February 26, 2026
Recommendations from the 2nd Consensus Workshop on Analytical Treatment Interruption in HIV Research TrialsThumbi Ndung'u, Krista L Dong, Donn J Colby, et al.
The Lancet. HIV|March 20, 2019
Recommendations for analytical antiretroviral treatment interruptions in HIV research trials-report of a consensus meetingBoris Julg, Lynda Dee, Jintanat Ananworanich, et al.
Nature Medicine|July 12, 2016
International AIDS Society global scientific strategy: towards an HIV cure 2016Steven G Deeks, Sharon R Lewin, Anna Laura Ross, et al.
Journal of Virus Eradication|July 21, 2025
Achieving the global agenda toward HIV cure calls for establishing a research-for-cure academy in West and Central AfricaAude Christelle Ka'e, Collins Ambe Chenwi, Livo Esemu, et al.
Pageof 9